CP
ABEV icon

Castleview Partners’s Ambev ABEV Stock Holding History

Castleview Partners’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,242
Closed -$9.08K – 900
2023
Q4 		$9.08K Sell
3,242
-5,276
-62% -$14.3K 0.01% 524
2023
Q3 		$22K Sell
8,518
-5,132
-38% -$14.8K 0.02% 348
2023
Q2 		$43.4K Buy
13,650
+5,485
+67% +$16.1K 0.04% 271
2023
Q1 		$23K Buy
8,165
+4,662
+133% +$12.2K 0.02% 330
2022
Q4 		$9.53K Buy
3,503
+1,716
+96% +$5K 0.01% 377
2022
Q3 		$5K Buy
1,787
+1,624
+996% +$4.61K ﹤0.01% 447
2022
Q2 		$78K Buy
+163
New +$465 0.06% 239
2021
Q2 		$94K Buy
+27,255
New +$88.7K 0.04% 299

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SIM
Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Castleview Partners's ABEV Position: Q1 2024 in Review

Castleview Partners sold out of Ambev (ABEV) in Q1 2024, closing a stake of 3,242 shares — an estimated $9.08K sold.

Castleview Partners first reported a position in ABEV in Q2 2021 and held it in 8 quarters. The position peaked at $94K in Q2 2021. 349 funds tracked by Wall St. Rank hold ABEV as of Q1 2024.

  • Castleview Partners reported no remaining Ambev position as of Q1 2024 after selling out during the quarter.
  • Castleview Partners sold 3,242 Ambev shares in Q1 2024, an estimated $9.08K.
  • Castleview Partners first reported a position in Ambev in Q2 2021 and held it in 8 quarters.
  • Castleview Partners's Ambev position peaked at $94K in Q2 2021.
  • 349 funds tracked by Wall St. Rank held Ambev as of Q1 2024.

Based on Castleview Partners's 13F filing for Q1 2024, filed 10 May 2024.